Axcelis Technologies
ACLS
$115.08
+4.27%
Axcelis Technologies Inc. designs, manufactures, and services ion implantation equipment essential for semiconductor chip fabrication, along with aftermarket lifecycle products such as spare parts, upgrades, and maintenance services. As a specialized player in the semiconductor capital equipment space, Axcelis holds a niche but critical position, deriving a significant portion of revenue from the Asia Pacific region. The current investor narrative centers on the company's growth trajectory amid cyclical semiconductor demand, recent volatility in its stock price, and mixed analyst sentiment reflecting uncertainty about near-term orders and the pace of recovery in the industry.…
ACLS
Axcelis Technologies
$115.08
Investment Opinion: Should I buy ACLS Today?
Based on the data, I rate ACLS as a Hold. The stock offers a compelling upside to analyst targets (39.9% to the average of $161.00), but the recent revenue deceleration and high valuation warrant caution. The consensus recommendation is 'Hold', reflecting the mixed sentiment among analysts.
Sign up to view all
ACLS 12-Month Price Forecast
The AI assessment leans neutral due to the conflicting signals. While the stock has strong profitability and a clean balance sheet, the recent revenue deceleration and high valuation cap upside. The key factor is the semiconductor cycle: if it recovers, ACLS could rally; if not, the stock may remain range-bound or decline. I would upgrade to bullish if revenue growth reaccelerates above 10% and the stock holds above $120, or downgrade to bearish if revenue declines further and the stock breaks below $100.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Axcelis Technologies's 12-month outlook, with a consensus price target around $161.00 and implied upside of +39.9% versus the current price.
Average Target
$161.00
0 analysts
Implied Upside
+39.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$140 - $198
Analyst target range
The target price range spans from a low of $140.00 to a high of $198.00, with the high target representing a 72.1% upside from the current price, likely assuming a strong recovery in semiconductor demand and successful execution of Axcelis's growth strategy. The low target of $140.00 still implies a 21.7% upside, indicating that even the most bearish analyst sees limited downside. Recent rating actions have been mixed: B. Riley upgraded from Neutral to Buy in April 2026, while B of A Securities maintained an Underperform rating as recently as June 2026, highlighting divergent views on the company's prospects. The wide spread between the low and high targets, coupled with the small number of analysts, suggests elevated uncertainty about Axcelis's future performance.
Drowning in data?
Find the real signal!
Bulls vs Bears: ACLS Investment Factors
Axcelis presents a mixed investment case. On the bullish side, the company boasts strong profitability, a clean balance sheet, and a strategic niche in semiconductor manufacturing, with analyst targets suggesting significant upside. However, the bearish case is equally compelling, driven by recent revenue deceleration, a high valuation relative to growth, and a steep drawdown from its peak. The most critical tension lies in whether the semiconductor capital equipment cycle will recover, as Axcelis's fortunes are closely tied to chipmaker spending. If demand rebounds, the stock could rally toward analyst targets; if not, the current valuation may be unjustified. Currently, the bearish evidence appears slightly stronger due to the immediate cyclical headwinds, but the long-term growth potential keeps the debate balanced.
Bullish
- Strong 1-Year Price Appreciation: ACLS has surged 46.06% over the past 12 months, significantly outperforming the S&P 500's 18.65% gain. This demonstrates robust momentum and investor confidence in the company's long-term growth prospects within the semiconductor equipment sector.
- Healthy Profitability Metrics: The company maintains a trailing PE of 21.09x and a net margin of 14.3%, indicating solid profitability. With a gross margin of 44.9% and operating margin of 14.2%, Axcelis efficiently converts revenue into profits, supporting its valuation.
- Minimal Debt and Strong Liquidity: Axcelis has a debt-to-equity ratio of just 0.041 and a current ratio of 4.77, reflecting a conservative balance sheet with ample liquidity. This financial stability provides a cushion against cyclical downturns and supports future investments.
- Analyst Targets Indicate Upside: The average analyst target price is $161.00, representing a 39.9% upside from the current price of $115.08. Even the low target of $140.00 implies a 21.7% gain, suggesting that analysts see limited downside risk.
Bearish
- Recent Revenue Deceleration: Q1 2026 revenue grew only 3.32% year-over-year to $198.96 million, a sharp slowdown from the 20%+ growth seen in prior quarters. Sequentially, revenue dropped 16.5% from Q4 2025's $238.33 million, highlighting the cyclicality of semiconductor capital equipment demand.
- High Valuation Relative to Growth: With a forward PE of 21.85x and a PEG ratio of -0.55 (negative due to expected earnings decline), the stock appears expensive given its muted growth prospects. The narrow gap between trailing and forward PE suggests the market expects little earnings expansion.
- Significant Drawdown from Peak: The stock trades at $115.08, which is 40.6% below its 52-week high of $193.78. This substantial decline indicates that investor sentiment has soured, and the stock may face resistance as it attempts to recover.
- Mixed Analyst Sentiment: While B. Riley upgraded to Buy in April 2026, B of A Securities maintained an Underperform rating in June 2026. With only 3 analysts covering the stock and a consensus recommendation of 'Hold', the lack of strong bullish conviction raises uncertainty.
ACLS Technical Analysis
Axcelis has experienced a dramatic and volatile price journey over the past year. The stock has surged 46.06% over the last 12 months, yet it currently trades at $115.08, which is only 59.4% of its 52-week range (between a low of $73.60 and a high of $193.78). This positioning near the lower end of the range suggests that while the longer-term trend has been upward, the stock has pulled back significantly from its peak, indicating a potential correction or consolidation phase after a strong run.
Beta
1.86
1.86x market volatility
Max Drawdown
-42.5%
Largest decline past year
52-Week Range
$74-$194
Price range past year
Annual Return
+46.1%
Cumulative gain past year
| Period | ACLS Return | S&P 500 |
|---|---|---|
| 1m | -15.8% | -0.4% |
| 3m | -21.8% | +4.5% |
| 6m | +39.9% | +13.9% |
| 1y | +46.1% | +19.0% |
| ytd | +33.6% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ACLS Fundamental Analysis
Axcelis's revenue trajectory has been uneven, with the most recent quarter (Q1 2026) showing revenue of $198.96 million, a modest 3.32% year-over-year increase. This growth is a slowdown compared to earlier quarters, such as Q4 2025's revenue of $238.33 million and Q3 2025's $213.61 million, indicating a deceleration in the company's top-line expansion. The sequential decline from Q4 2025 to Q1 2026 (a drop of 16.5%) highlights the cyclicality of the semiconductor equipment market, where order timing can cause significant quarterly fluctuations.
Quarterly Revenue
$198956000.0B
2026-03
Revenue YoY Growth
+3.3%
YoY Comparison
Gross Margin
40.5%
Latest Quarter
Free Cash Flow
$88475000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ACLS Overvalued?
Given that Axcelis is profitable, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 21.09x, while the forward PE is slightly higher at 21.85x, implying that the market expects earnings to remain relatively stable or grow modestly in the coming year. The narrow gap between trailing and forward multiples suggests limited growth expectations, which is consistent with the company's recent revenue deceleration and the cyclical downturn in semiconductor capital spending.
PE
21.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Axcelis faces risks from its revenue concentration in the cyclical semiconductor equipment market. The recent 16.5% sequential revenue decline in Q1 2026 highlights the volatility in order timing, which can cause significant earnings fluctuations. While the company has minimal debt (debt-to-equity of 0.041) and a strong current ratio of 4.77, its net margin of 14.3% could compress if revenue continues to fall, as fixed costs remain. Additionally, the negative PEG ratio (-0.55) suggests that earnings are expected to decline, which could pressure the stock if the trend persists.
FAQ
The primary risks include: 1) Cyclicality of the semiconductor equipment market, as evidenced by the 16.5% sequential revenue decline in Q1 2026. 2) High valuation risk, with a forward PE of 21.85x that may not be justified if earnings decline. 3) Market risk due to a beta of 1.856, making the stock more volatile than the market. 4) Competitive risk from larger players like Applied Materials, which could erode Axcelis's market share. The most severe risk is a prolonged industry downturn, which could push the stock down to its 52-week low of $73.60, representing a 36% loss from the current price.
Over the next 12 months, the bull case (25% probability) targets $161-$198, the base case (50% probability) targets $140-$161, and the bear case (25% probability) targets $73.60-$140. The most likely scenario is the base case, where the semiconductor cycle stabilizes and the stock reaches the average analyst target of $161.00. This forecast assumes that Axcelis maintains modest revenue growth and profitability. If the industry recovery is stronger than expected, the stock could exceed $198, but if the downturn persists, it could fall below $100.
ACLS trades at a trailing PE of 21.09x and a forward PE of 21.85x, which is in line with the broader semiconductor industry. However, the negative PEG ratio (-0.55) indicates that the market expects earnings to decline, making the stock appear overvalued relative to its growth prospects. Compared to its own history, the stock is trading at a discount to its 52-week high of $193.78, but the current valuation still implies that investors are paying a premium for future earnings. The market is likely pricing in a recovery in semiconductor demand, but if that recovery is delayed, the stock could be considered overvalued.
ACLS offers a potential upside of 39.9% to the average analyst target of $161.00, but the stock is not without risks. The recent revenue deceleration and high valuation (forward PE of 21.85x) suggest that the market is pricing in modest growth. For investors with a long-term horizon and tolerance for volatility, ACLS could be a good buy if the semiconductor cycle recovers. However, given the mixed analyst sentiment and the stock's 40.6% drawdown from its high, a more cautious approach may be prudent. It is best suited for those who believe in the long-term growth of semiconductor manufacturing and can withstand short-term fluctuations.
ACLS is better suited for long-term investment, given its cyclical nature and high beta of 1.856. Short-term trading is risky due to the stock's volatility, as seen in its 40.6% drawdown from the 52-week high. For long-term investors, the company's niche position in ion implantation and strong profitability provide a foundation for growth over a 3-5 year horizon. However, investors should be prepared for significant price swings and should focus on the company's fundamentals rather than short-term market movements. A minimum holding period of 3 years is recommended to ride out the semiconductor cycle.
